These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32496102)

  • 1. Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic.
    McCann Pineo M; Schwartz RM
    Psychol Trauma; 2020 Aug; 12(S1):S108-S110. PubMed ID: 32496102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine.
    Henry BF; Mandavia AD; Paschen-Wolff MM; Hunt T; Humensky JL; Wu E; Pincus HA; Nunes EV; Levin FR; El-Bassel N
    Psychol Trauma; 2020 Aug; 12(S1):S111-S112. PubMed ID: 32551759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids: The Forgotten Epidemic?
    Price S
    Tex Med; 2020 Oct; 116(10):32-35. PubMed ID: 33126270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and U.S.-based refugee populations: Commentary.
    Mattar S; Piwowarczyk LA
    Psychol Trauma; 2020 Aug; 12(S1):S228-S229. PubMed ID: 32538665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
    Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
    J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
    Green TC; Bratberg J; Finnell DS
    Subst Abus; 2020; 41(2):147-149. PubMed ID: 32314951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
    Krawczyk N; Fingerhood MI; Agus D
    J Subst Abuse Treat; 2020 Oct; 117():108074. PubMed ID: 32680610
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
    Uscher-Pines L; Sousa J; Raja P; Mehrotra A; Barnett M; Huskamp HA
    J Subst Abuse Treat; 2020 Nov; 118():108124. PubMed ID: 32893047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
    Crowley D; Delargy I
    Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.
    Narayan A; Balkrishnan R
    Subst Abus; 2021; 42(2):148-152. PubMed ID: 33849399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic.
    McKiever ME; Cleary EM; Schmauder T; Talley A; Hinely KA; Costantine MM; Rood KM
    Am J Obstet Gynecol; 2020 Nov; 223(5):770-772. PubMed ID: 32771380
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
    Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
    Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
    [No Abstract]   [Full Text] [Related]  

  • 13. The escalation of the opioid epidemic due to COVID-19 and resulting lessons about treatment alternatives.
    Silva MJ; Kelly Z
    Am J Manag Care; 2020 Jul; 26(7):e202-e204. PubMed ID: 32672917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic.
    Li R; Zhao M
    Curr Opin Psychiatry; 2021 Jul; 34(4):369-375. PubMed ID: 33859127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deafness and mental health: Clinical challenges during the COVID-19 pandemic.
    Recio-Barbero M; Sáenz-Herrero M; Segarra R
    Psychol Trauma; 2020 Aug; 12(S1):S212-S213. PubMed ID: 32478542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?
    Trujols J; Larrabeiti A; Sànchez O; Madrid M; De Andrés S; Duran-Sindreu S
    J Subst Abuse Treat; 2020 Dec; 119():108154. PubMed ID: 33032860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in Malta: The mental health impact.
    Grech P; Grech R
    Psychol Trauma; 2020 Jul; 12(5):534-535. PubMed ID: 32478546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychological effects of the COVID-19 pandemic and coping with them in Saudi Arabia.
    AlHumaid J; Ali S; Farooq I
    Psychol Trauma; 2020 Jul; 12(5):505-507. PubMed ID: 32584104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caring for patients with posttraumatic stress and substance use disorders during the COVID-19 pandemic.
    Banducci AN; Weiss NH
    Psychol Trauma; 2020 Aug; 12(S1):S113-S114. PubMed ID: 32525388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating psychiatry teleclinics during the COVID-19 pandemic in a tertiary care hospital in Karachi, Pakistan.
    Nadeem T; Siddiqui S; Asad N
    Psychol Trauma; 2020 Oct; 12(7):807-808. PubMed ID: 32853009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.